Treace Medical Concepts Inc - Asset Resilience Ratio
Treace Medical Concepts Inc (TMCI) has an Asset Resilience Ratio of 22.98% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Treace Medical Concepts Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Treace Medical Concepts Inc's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Treace Medical Concepts Inc to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Treace Medical Concepts Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see TMCI stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $42.31 Million | 22.98% |
| Total Liquid Assets | $42.31 Million | 22.98% |
Asset Resilience Insights
- Good Liquidity Position: Treace Medical Concepts Inc maintains a healthy 22.98% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Treace Medical Concepts Inc Industry Peers by Asset Resilience Ratio
Compare Treace Medical Concepts Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Treace Medical Concepts Inc (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Treace Medical Concepts Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 19.76% | $37.66 Million | $190.58 Million | -9.87pp |
| 2024-12-31 | 29.63% | $64.33 Million | $217.09 Million | -14.12pp |
| 2023-12-31 | 43.75% | $110.22 Million | $251.91 Million | +4.90pp |
| 2022-12-31 | 38.85% | $61.78 Million | $159.02 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $140.82 Million | -- |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more